CN Stock MarketDetailed Quotes

300759 Pharmaron Beijing

Watchlist
  • 26.03
  • -1.20-4.41%
Market Closed Dec 27 15:00 CST
46.28BMarket Cap24.56P/E (TTM)

Pharmaron Beijing Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-2.80%2B
-4.45%2.4B
125.41%4.63B
295.26%5.92B
0.79%2.06B
-11.79%2.51B
-29.45%2.06B
-57.74%1.5B
-52.39%2.04B
-52.27%2.85B
Transactional financial assets
-35.42%596.88M
-43.33%361.09M
17.04%574.79M
-16.55%621.98M
32.37%924.25M
6.62%637.2M
-65.69%491.1M
-52.06%745.36M
-57.99%698.21M
-21.07%597.63M
Notes receivable and accounts receivable
2.27%2.27B
1.92%2.18B
1.00%2.09B
19.14%2.24B
23.35%2.22B
32.31%2.14B
60.73%2.07B
53.14%1.88B
54.91%1.8B
43.34%1.62B
-Notes receivable
--1.04M
----
----
--127.66K
----
----
----
----
----
----
-Accounts receivable
2.22%2.27B
1.92%2.18B
1.00%2.09B
19.14%2.24B
23.35%2.22B
32.31%2.14B
60.73%2.07B
53.14%1.88B
54.91%1.8B
43.34%1.62B
Other receivables (including interest and dividends)
72.79%164.88M
30.32%145.23M
18.76%141.24M
19.43%113.13M
-35.29%95.42M
-9.14%111.44M
-2.73%118.92M
-18.40%94.73M
61.13%147.46M
19.46%122.65M
-Other receivable
----
30.32%145.23M
----
----
----
-9.14%111.44M
----
-18.40%94.73M
----
19.46%122.65M
Contractual assets
16.28%455.88M
8.37%427.29M
7.60%424.48M
18.54%394.27M
19.94%392.06M
42.65%394.3M
57.83%394.5M
70.58%332.6M
74.58%326.88M
51.33%276.4M
Advance payment
-13.19%25.57M
-8.68%26.04M
-12.84%26.05M
-22.70%17.81M
-45.65%29.46M
-1.11%28.51M
21.70%29.89M
-7.67%23.04M
82.20%54.2M
66.59%28.83M
Inventories
20.17%1.2B
14.30%1.19B
-0.10%1.07B
-2.73%1.01B
-2.24%995.03M
12.52%1.04B
35.99%1.07B
53.15%1.04B
79.34%1.02B
107.42%923.71M
Non-current assets due within one year
----
----
3,899.46%145.66M
5,353.66%144.33M
8,923.34%145.21M
29,368.28%145.03M
--3.64M
--2.65M
--1.61M
--492.17K
Other current assets
7.56%385.62M
-19.08%343.27M
5.60%344.56M
-55.42%408.74M
-36.32%358.5M
-27.76%424.19M
-60.69%326.3M
-29.49%916.8M
-15.27%562.95M
171.05%587.21M
Total current assets
-1.70%7.1B
-4.84%7.07B
44.06%9.45B
66.38%10.87B
8.53%7.22B
6.13%7.43B
-14.22%6.56B
-24.38%6.54B
-23.13%6.65B
-20.60%7B
Non Current assets
Debt investment
----
----
----
----
----
----
--137.43M
--139.29M
--142M
--134.23M
Other non-current financial assets
-18.60%235.86M
-8.32%233.76M
7.83%283.7M
17.98%282.03M
11.14%289.77M
2.68%254.98M
0.01%263.1M
-22.90%239.05M
-7.63%260.73M
25.27%248.31M
Long-term equity investment
27.87%856.22M
12.82%734.24M
15.49%737.05M
14.76%722.95M
1.30%669.61M
8.94%650.79M
10.35%638.22M
39.19%629.97M
75.92%660.99M
100.34%597.36M
Fixed assets
----
22.76%7.4B
----
----
----
20.49%6.03B
----
44.41%5.66B
----
47.45%5B
Constru in process
----
-17.04%2B
----
----
----
107.55%2.41B
----
21.63%1.67B
----
10.73%1.16B
Productive biological assets
-18.55%156.07M
-16.89%156.56M
-12.65%156.91M
-11.45%157.63M
-3.78%191.61M
-2.70%188.36M
6.01%179.63M
24.28%178.02M
408.82%199.13M
444.49%193.58M
Intangible assets
1.89%800.92M
-2.37%786.01M
-4.99%787.46M
-1.68%789.06M
8.72%786.04M
11.14%805.05M
10.74%828.79M
15.82%802.53M
11.27%723.01M
10.69%724.39M
Goodwill
2.81%2.84B
-0.94%2.79B
3.36%2.78B
3.46%2.78B
7.83%2.76B
10.98%2.81B
13.69%2.69B
28.22%2.69B
41.30%2.56B
40.50%2.54B
Long deferred expense
47.53%675.86M
47.08%705.14M
4.80%503.91M
4.85%520.47M
26.26%458.13M
97.89%479.42M
132.50%480.83M
189.26%496.38M
92.92%362.84M
21.95%242.27M
Deferred tax assets
34.69%207.51M
37.86%190.34M
178.77%193.4M
160.62%153.22M
243.13%154.07M
301.14%138.07M
206.11%69.38M
276.97%58.79M
188.62%44.9M
172.53%34.42M
Usufruct assets
-28.55%585.42M
-28.64%618.12M
-29.29%644.99M
-18.38%775.63M
1.46%819.32M
9.11%866.23M
69.59%912.22M
156.09%950.25M
170.76%807.53M
197.38%793.93M
Other non current assets
20.67%316.61M
-2.84%314.85M
-22.67%342.29M
-33.65%291.22M
-40.68%262.37M
8.97%324.07M
48.77%442.66M
123.94%438.91M
-2.96%442.28M
-3.67%297.4M
Total non current assets
7.97%16.47B
6.46%15.93B
9.02%15.8B
11.79%15.6B
16.86%15.26B
25.02%14.96B
31.54%14.49B
43.21%13.96B
46.99%13.05B
45.57%11.97B
Total assets
4.87%23.57B
2.71%23B
19.94%25.24B
29.20%26.48B
14.05%22.48B
18.05%22.39B
12.79%21.05B
11.44%20.49B
12.38%19.71B
11.32%18.97B
Liabilities
Current liabilities
Short term loan
20.53%644.67M
20.49%556.13M
-19.52%534.47M
-12.93%577.07M
33.45%534.85M
12.84%461.54M
60.62%664.08M
57.14%662.77M
-1.64%400.79M
5.05%409.03M
Transactional financial liabilities
-80.47%26.54M
-70.84%50.03M
29.07%32.97M
-10.34%26.93M
27.71%135.93M
1,715.48%171.55M
--25.55M
--30.04M
--106.43M
-93.50%9.45M
Notes payable and accounts payable
21.11%485.59M
20.78%503.04M
-10.17%385.09M
1.45%412.22M
-13.80%400.93M
-10.70%416.5M
20.83%428.66M
28.78%406.35M
63.96%465.1M
73.74%466.38M
-Accounts payable
21.11%485.59M
20.78%503.04M
-10.17%385.09M
1.45%412.22M
-13.80%400.93M
-10.70%416.5M
20.83%428.66M
28.78%406.35M
63.96%465.1M
73.74%466.38M
Contract liabilities
5.31%899.24M
-8.78%796.97M
5.66%836.88M
-10.97%740.87M
0.60%853.93M
4.42%873.66M
6.13%792.08M
22.44%832.14M
28.19%848.81M
35.90%836.71M
Salaries payable
-6.91%609.74M
-0.36%586.88M
3.37%727.83M
7.23%668.66M
15.63%654.97M
20.90%588.98M
28.82%704.07M
17.99%623.56M
27.53%566.44M
30.25%487.15M
Taxs payable
-0.17%248.53M
2.41%222.09M
21.62%236.07M
26.38%237.95M
23.97%248.94M
56.52%216.87M
54.62%194.11M
64.89%188.29M
63.07%200.8M
39.22%138.56M
Other payable (including interest and dividends)
32.78%765.14M
-29.70%720.54M
-22.85%647.54M
-30.57%630.54M
-28.07%576.23M
25.86%1.02B
20.26%839.38M
20.63%908.12M
52.83%801.09M
56.19%814.3M
-Dividend payable
----
-83.61%58.85M
----
----
----
547.64%359.03M
23.89%1.69M
36.78%1.86M
34.76%1.86M
562.01%55.44M
-Other payable
----
-0.63%661.68M
----
----
----
-12.25%665.88M
----
20.60%906.25M
----
47.93%758.86M
Non current liabilities due within one year
62.66%451.99M
69.43%449.39M
25.82%329.99M
40.45%335.66M
17.42%277.88M
23.26%265.24M
40.81%262.28M
53.35%238.98M
120.93%236.66M
111.45%215.19M
Other current liabilities
-15.93%24.6M
9.42%25.62M
2.89%25.26M
10.74%24.59M
44.30%29.26M
26.20%23.41M
56.79%24.55M
61.09%22.2M
--20.28M
--18.55M
Total current liabilities
11.93%4.16B
-3.26%3.91B
-4.54%3.76B
-6.59%3.65B
1.82%3.71B
19.07%4.04B
27.48%3.93B
31.20%3.91B
42.89%3.65B
34.98%3.4B
Current liabilities
Long term loan
396.25%4.33B
419.98%4.33B
474.88%4.39B
503.94%4.31B
26.03%872.58M
42.50%832.16M
-14.48%764.01M
-25.39%713.34M
-25.81%692.34M
-32.02%583.95M
Bonds payable
----
-99.74%10.26M
-32.42%2.53B
4.03%3.89B
3.72%3.89B
7.15%3.87B
7.38%3.74B
7.90%3.74B
8.06%3.75B
5.17%3.61B
Deferred tax liabilities
2.54%263.49M
-9.32%241.51M
-0.33%266.64M
11.12%290.04M
33.32%256.96M
29.76%266.33M
36.33%267.52M
50.61%261.01M
66.62%192.74M
82.20%205.24M
Long term deferred income
34.01%381.53M
34.46%384.87M
76.26%386.49M
157.07%391.71M
83.43%284.71M
80.57%286.22M
49.62%219.27M
1.96%152.38M
1.74%155.22M
2.13%158.51M
Lease liabilities
-33.11%412.71M
-32.97%450.54M
-35.33%466.16M
-23.05%585.2M
-1.67%617.05M
7.02%672.15M
72.45%720.82M
167.47%760.51M
176.22%627.51M
212.77%628.05M
Other non current liabilities
----
----
-27.25%89.37M
4.90%117.58M
13.90%115.86M
19.99%111.13M
38.15%122.85M
37.44%112.09M
-43.96%101.73M
-63.65%92.61M
Total non current liabilities
-10.74%5.39B
-10.37%5.41B
39.27%8.13B
66.96%9.58B
9.37%6.04B
14.35%6.04B
11.64%5.84B
12.29%5.74B
8.64%5.52B
5.25%5.28B
Total liabilities
-2.11%9.54B
-7.52%9.32B
21.63%11.89B
37.15%13.24B
6.37%9.75B
16.20%10.08B
17.52%9.77B
19.26%9.65B
20.09%9.17B
15.17%8.68B
Shareholders equity
Paid-in capital
0.04%1.79B
0.04%1.79B
50.05%1.79B
50.05%1.79B
50.01%1.79B
50.01%1.79B
49.99%1.19B
49.99%1.19B
49.98%1.19B
49.94%1.19B
Other equity instruments
----
----
-40.55%118.04M
0.00%198.55M
0.00%198.55M
0.00%198.55M
0.00%198.55M
0.00%198.55M
0.00%198.55M
0.00%198.55M
Capital reserve funds
2.67%5.19B
3.93%5.17B
-1.19%5.26B
-0.62%5.22B
-11.11%5.06B
-11.60%4.97B
-11.70%5.32B
-12.55%5.25B
-6.29%5.69B
-7.04%5.63B
Surplus reserve funds
45.47%613.04M
45.47%613.04M
45.47%613.04M
45.47%613.04M
26.70%421.42M
26.70%421.42M
26.70%421.42M
26.70%421.42M
64.28%332.62M
64.28%332.62M
Retained profit
27.12%6.27B
30.19%5.96B
20.76%5.44B
25.34%5.2B
28.90%4.93B
32.71%4.58B
29.67%4.5B
28.88%4.15B
40.16%3.83B
53.04%3.45B
Less:Treasury stock
13.91%527.94M
3.35%478.97M
-28.72%463.45M
-30.62%463.45M
-30.62%463.45M
-4.28%463.45M
48.79%650.2M
121.33%668.04M
359.95%668.04M
494.86%484.16M
Other composite income
285.80%51.71M
-215.29%-42.34M
-2,352.69%-59.7M
-273.55%-4.83M
83.39%-27.83M
122.75%36.72M
98.64%-2.43M
98.96%-1.29M
-81.93%-167.59M
-188.62%-161.41M
Shareholders equity without minority interests
12.45%13.39B
12.81%13.01B
15.55%12.69B
19.04%12.56B
14.45%11.9B
13.59%11.54B
7.59%10.98B
4.14%10.55B
6.60%10.4B
8.42%10.16B
Minority interests
-22.25%638.87M
-14.62%658.78M
126.95%669.92M
133.90%681.25M
489.24%821.75M
477.79%771.57M
110.93%295.18M
75.38%291.25M
-4.48%139.46M
-2.26%133.54M
Total shareholder equity
10.21%14.03B
11.09%13.67B
18.47%13.36B
22.12%13.24B
20.73%12.73B
19.61%12.31B
8.99%11.27B
5.29%10.84B
6.43%10.54B
8.27%10.29B
Total liabilityies and equity
4.87%23.57B
2.71%23B
19.94%25.24B
29.20%26.48B
14.05%22.48B
18.05%22.39B
12.79%21.05B
11.44%20.49B
12.38%19.71B
11.32%18.97B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Ernst & Young Huaming Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young Huaming Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -2.80%2B-4.45%2.4B125.41%4.63B295.26%5.92B0.79%2.06B-11.79%2.51B-29.45%2.06B-57.74%1.5B-52.39%2.04B-52.27%2.85B
Transactional financial assets -35.42%596.88M-43.33%361.09M17.04%574.79M-16.55%621.98M32.37%924.25M6.62%637.2M-65.69%491.1M-52.06%745.36M-57.99%698.21M-21.07%597.63M
Notes receivable and accounts receivable 2.27%2.27B1.92%2.18B1.00%2.09B19.14%2.24B23.35%2.22B32.31%2.14B60.73%2.07B53.14%1.88B54.91%1.8B43.34%1.62B
-Notes receivable --1.04M----------127.66K------------------------
-Accounts receivable 2.22%2.27B1.92%2.18B1.00%2.09B19.14%2.24B23.35%2.22B32.31%2.14B60.73%2.07B53.14%1.88B54.91%1.8B43.34%1.62B
Other receivables (including interest and dividends) 72.79%164.88M30.32%145.23M18.76%141.24M19.43%113.13M-35.29%95.42M-9.14%111.44M-2.73%118.92M-18.40%94.73M61.13%147.46M19.46%122.65M
-Other receivable ----30.32%145.23M-------------9.14%111.44M-----18.40%94.73M----19.46%122.65M
Contractual assets 16.28%455.88M8.37%427.29M7.60%424.48M18.54%394.27M19.94%392.06M42.65%394.3M57.83%394.5M70.58%332.6M74.58%326.88M51.33%276.4M
Advance payment -13.19%25.57M-8.68%26.04M-12.84%26.05M-22.70%17.81M-45.65%29.46M-1.11%28.51M21.70%29.89M-7.67%23.04M82.20%54.2M66.59%28.83M
Inventories 20.17%1.2B14.30%1.19B-0.10%1.07B-2.73%1.01B-2.24%995.03M12.52%1.04B35.99%1.07B53.15%1.04B79.34%1.02B107.42%923.71M
Non-current assets due within one year --------3,899.46%145.66M5,353.66%144.33M8,923.34%145.21M29,368.28%145.03M--3.64M--2.65M--1.61M--492.17K
Other current assets 7.56%385.62M-19.08%343.27M5.60%344.56M-55.42%408.74M-36.32%358.5M-27.76%424.19M-60.69%326.3M-29.49%916.8M-15.27%562.95M171.05%587.21M
Total current assets -1.70%7.1B-4.84%7.07B44.06%9.45B66.38%10.87B8.53%7.22B6.13%7.43B-14.22%6.56B-24.38%6.54B-23.13%6.65B-20.60%7B
Non Current assets
Debt investment --------------------------137.43M--139.29M--142M--134.23M
Other non-current financial assets -18.60%235.86M-8.32%233.76M7.83%283.7M17.98%282.03M11.14%289.77M2.68%254.98M0.01%263.1M-22.90%239.05M-7.63%260.73M25.27%248.31M
Long-term equity investment 27.87%856.22M12.82%734.24M15.49%737.05M14.76%722.95M1.30%669.61M8.94%650.79M10.35%638.22M39.19%629.97M75.92%660.99M100.34%597.36M
Fixed assets ----22.76%7.4B------------20.49%6.03B----44.41%5.66B----47.45%5B
Constru in process -----17.04%2B------------107.55%2.41B----21.63%1.67B----10.73%1.16B
Productive biological assets -18.55%156.07M-16.89%156.56M-12.65%156.91M-11.45%157.63M-3.78%191.61M-2.70%188.36M6.01%179.63M24.28%178.02M408.82%199.13M444.49%193.58M
Intangible assets 1.89%800.92M-2.37%786.01M-4.99%787.46M-1.68%789.06M8.72%786.04M11.14%805.05M10.74%828.79M15.82%802.53M11.27%723.01M10.69%724.39M
Goodwill 2.81%2.84B-0.94%2.79B3.36%2.78B3.46%2.78B7.83%2.76B10.98%2.81B13.69%2.69B28.22%2.69B41.30%2.56B40.50%2.54B
Long deferred expense 47.53%675.86M47.08%705.14M4.80%503.91M4.85%520.47M26.26%458.13M97.89%479.42M132.50%480.83M189.26%496.38M92.92%362.84M21.95%242.27M
Deferred tax assets 34.69%207.51M37.86%190.34M178.77%193.4M160.62%153.22M243.13%154.07M301.14%138.07M206.11%69.38M276.97%58.79M188.62%44.9M172.53%34.42M
Usufruct assets -28.55%585.42M-28.64%618.12M-29.29%644.99M-18.38%775.63M1.46%819.32M9.11%866.23M69.59%912.22M156.09%950.25M170.76%807.53M197.38%793.93M
Other non current assets 20.67%316.61M-2.84%314.85M-22.67%342.29M-33.65%291.22M-40.68%262.37M8.97%324.07M48.77%442.66M123.94%438.91M-2.96%442.28M-3.67%297.4M
Total non current assets 7.97%16.47B6.46%15.93B9.02%15.8B11.79%15.6B16.86%15.26B25.02%14.96B31.54%14.49B43.21%13.96B46.99%13.05B45.57%11.97B
Total assets 4.87%23.57B2.71%23B19.94%25.24B29.20%26.48B14.05%22.48B18.05%22.39B12.79%21.05B11.44%20.49B12.38%19.71B11.32%18.97B
Liabilities
Current liabilities
Short term loan 20.53%644.67M20.49%556.13M-19.52%534.47M-12.93%577.07M33.45%534.85M12.84%461.54M60.62%664.08M57.14%662.77M-1.64%400.79M5.05%409.03M
Transactional financial liabilities -80.47%26.54M-70.84%50.03M29.07%32.97M-10.34%26.93M27.71%135.93M1,715.48%171.55M--25.55M--30.04M--106.43M-93.50%9.45M
Notes payable and accounts payable 21.11%485.59M20.78%503.04M-10.17%385.09M1.45%412.22M-13.80%400.93M-10.70%416.5M20.83%428.66M28.78%406.35M63.96%465.1M73.74%466.38M
-Accounts payable 21.11%485.59M20.78%503.04M-10.17%385.09M1.45%412.22M-13.80%400.93M-10.70%416.5M20.83%428.66M28.78%406.35M63.96%465.1M73.74%466.38M
Contract liabilities 5.31%899.24M-8.78%796.97M5.66%836.88M-10.97%740.87M0.60%853.93M4.42%873.66M6.13%792.08M22.44%832.14M28.19%848.81M35.90%836.71M
Salaries payable -6.91%609.74M-0.36%586.88M3.37%727.83M7.23%668.66M15.63%654.97M20.90%588.98M28.82%704.07M17.99%623.56M27.53%566.44M30.25%487.15M
Taxs payable -0.17%248.53M2.41%222.09M21.62%236.07M26.38%237.95M23.97%248.94M56.52%216.87M54.62%194.11M64.89%188.29M63.07%200.8M39.22%138.56M
Other payable (including interest and dividends) 32.78%765.14M-29.70%720.54M-22.85%647.54M-30.57%630.54M-28.07%576.23M25.86%1.02B20.26%839.38M20.63%908.12M52.83%801.09M56.19%814.3M
-Dividend payable -----83.61%58.85M------------547.64%359.03M23.89%1.69M36.78%1.86M34.76%1.86M562.01%55.44M
-Other payable -----0.63%661.68M-------------12.25%665.88M----20.60%906.25M----47.93%758.86M
Non current liabilities due within one year 62.66%451.99M69.43%449.39M25.82%329.99M40.45%335.66M17.42%277.88M23.26%265.24M40.81%262.28M53.35%238.98M120.93%236.66M111.45%215.19M
Other current liabilities -15.93%24.6M9.42%25.62M2.89%25.26M10.74%24.59M44.30%29.26M26.20%23.41M56.79%24.55M61.09%22.2M--20.28M--18.55M
Total current liabilities 11.93%4.16B-3.26%3.91B-4.54%3.76B-6.59%3.65B1.82%3.71B19.07%4.04B27.48%3.93B31.20%3.91B42.89%3.65B34.98%3.4B
Current liabilities
Long term loan 396.25%4.33B419.98%4.33B474.88%4.39B503.94%4.31B26.03%872.58M42.50%832.16M-14.48%764.01M-25.39%713.34M-25.81%692.34M-32.02%583.95M
Bonds payable -----99.74%10.26M-32.42%2.53B4.03%3.89B3.72%3.89B7.15%3.87B7.38%3.74B7.90%3.74B8.06%3.75B5.17%3.61B
Deferred tax liabilities 2.54%263.49M-9.32%241.51M-0.33%266.64M11.12%290.04M33.32%256.96M29.76%266.33M36.33%267.52M50.61%261.01M66.62%192.74M82.20%205.24M
Long term deferred income 34.01%381.53M34.46%384.87M76.26%386.49M157.07%391.71M83.43%284.71M80.57%286.22M49.62%219.27M1.96%152.38M1.74%155.22M2.13%158.51M
Lease liabilities -33.11%412.71M-32.97%450.54M-35.33%466.16M-23.05%585.2M-1.67%617.05M7.02%672.15M72.45%720.82M167.47%760.51M176.22%627.51M212.77%628.05M
Other non current liabilities ---------27.25%89.37M4.90%117.58M13.90%115.86M19.99%111.13M38.15%122.85M37.44%112.09M-43.96%101.73M-63.65%92.61M
Total non current liabilities -10.74%5.39B-10.37%5.41B39.27%8.13B66.96%9.58B9.37%6.04B14.35%6.04B11.64%5.84B12.29%5.74B8.64%5.52B5.25%5.28B
Total liabilities -2.11%9.54B-7.52%9.32B21.63%11.89B37.15%13.24B6.37%9.75B16.20%10.08B17.52%9.77B19.26%9.65B20.09%9.17B15.17%8.68B
Shareholders equity
Paid-in capital 0.04%1.79B0.04%1.79B50.05%1.79B50.05%1.79B50.01%1.79B50.01%1.79B49.99%1.19B49.99%1.19B49.98%1.19B49.94%1.19B
Other equity instruments ---------40.55%118.04M0.00%198.55M0.00%198.55M0.00%198.55M0.00%198.55M0.00%198.55M0.00%198.55M0.00%198.55M
Capital reserve funds 2.67%5.19B3.93%5.17B-1.19%5.26B-0.62%5.22B-11.11%5.06B-11.60%4.97B-11.70%5.32B-12.55%5.25B-6.29%5.69B-7.04%5.63B
Surplus reserve funds 45.47%613.04M45.47%613.04M45.47%613.04M45.47%613.04M26.70%421.42M26.70%421.42M26.70%421.42M26.70%421.42M64.28%332.62M64.28%332.62M
Retained profit 27.12%6.27B30.19%5.96B20.76%5.44B25.34%5.2B28.90%4.93B32.71%4.58B29.67%4.5B28.88%4.15B40.16%3.83B53.04%3.45B
Less:Treasury stock 13.91%527.94M3.35%478.97M-28.72%463.45M-30.62%463.45M-30.62%463.45M-4.28%463.45M48.79%650.2M121.33%668.04M359.95%668.04M494.86%484.16M
Other composite income 285.80%51.71M-215.29%-42.34M-2,352.69%-59.7M-273.55%-4.83M83.39%-27.83M122.75%36.72M98.64%-2.43M98.96%-1.29M-81.93%-167.59M-188.62%-161.41M
Shareholders equity without minority interests 12.45%13.39B12.81%13.01B15.55%12.69B19.04%12.56B14.45%11.9B13.59%11.54B7.59%10.98B4.14%10.55B6.60%10.4B8.42%10.16B
Minority interests -22.25%638.87M-14.62%658.78M126.95%669.92M133.90%681.25M489.24%821.75M477.79%771.57M110.93%295.18M75.38%291.25M-4.48%139.46M-2.26%133.54M
Total shareholder equity 10.21%14.03B11.09%13.67B18.47%13.36B22.12%13.24B20.73%12.73B19.61%12.31B8.99%11.27B5.29%10.84B6.43%10.54B8.27%10.29B
Total liabilityies and equity 4.87%23.57B2.71%23B19.94%25.24B29.20%26.48B14.05%22.48B18.05%22.39B12.79%21.05B11.44%20.49B12.38%19.71B11.32%18.97B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Ernst & Young Huaming Certified Public Accountants (Special General Partnership)------Ernst & Young Huaming Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Top CN Stock Gainers
Symbol Price % Chg
Suzhou Industrial Park Heshun Electric
300141
11.14 +20.04%
Guangdong Xiongsu Technology Group
300599
7.67 +20.03%
Sichuan Chuanhuan Technology
300547
24.41 +20.01%
Shanghai Wisdom Information Technology
301315
65.82 +20.00%
KANGNONG SEED
837403
22.69 +19.86%

See the daily top gainer.

Investment Theme Biomedical
Biomedical
Intraday+0.69%
Innovative Drugs
Innovative Drugs
Intraday+0.47%